Pediatric medulloblastoma xenografts including molecular subgroup 3 and CD133+ and CD15+ cells are sensitive to killing by oncolytic herpes simplex viruses.
about
Oncolytic virotherapy for pediatric malignancies: future prospectsPediatric cancer gone viral. Part II: potential clinical application of oncolytic herpes simplex virus-1 in children.Pediatric cancer gone viral. Part I: strategies for utilizing oncolytic herpes simplex virus-1 in children.Effect of Repeat Dosing of Engineered Oncolytic Herpes Simplex Virus on Preclinical Models of RhabdomyosarcomaOncolytic Virotherapy for the Treatment of Malignant Glioma.Brain Cancer Stem Cells in Adults and Children: Cell Biology and Therapeutic Implications.Modulation of the Intratumoral Immune Landscape by Oncolytic Herpes Simplex Virus Virotherapy.Oncolytic Herpes Virus rRp450 Shows Efficacy in Orthotopic Xenograft Group 3/4 Medulloblastomas and Atypical Teratoid/Rhabdoid Tumors.Rationale and Design of a Phase 1 Clinical Trial to Evaluate HSV G207 Alone or with a Single Radiation Dose in Children with Progressive or Recurrent Malignant Supratentorial Brain Tumors.Immunotherapy for brain tumors: understanding early successes and limitations.Glycosylation Changes in Brain Cancer.FTY720 Decreases Tumorigenesis in Group 3 Medulloblastoma Patient-Derived Xenografts.Oncolytic Viruses as Therapeutic Tools for Pediatric Brain TumorsEnhanced Sensitivity of Patient-Derived Pediatric High-Grade Brain Tumor Xenografts to Oncolytic HSV-1 Virotherapy Correlates with Nectin-1 Expression
P2860
Q28069358-9B3BF203-A4BB-4CC4-9EE1-E099F95F607FQ36109700-DCBF379E-07D8-4AD7-98DB-B5B54FC41FB7Q36109704-BA711E55-F23E-4767-977D-1EAD3E870893Q37346179-3527B1E8-2211-48EC-8FFB-DAFDBEA0246FQ38749871-760940BF-61CB-4A0F-B5DD-E242F03D3B3BQ39218100-7287BA8F-BCA1-4EA9-8D40-E3D5EF91E5EFQ39427382-E79E4751-BDB6-4672-9DD9-D3645C6BD309Q40145892-8221209B-484D-4B82-8F77-320C0AA8756EQ40284855-A4FFA78C-0788-4B99-BAC6-B0AE168EEB7AQ47555498-5599FA10-7C21-4648-9FCD-92C06CC0067AQ47691736-4240D977-ED10-40A5-BE92-12A17855142DQ52714457-032A35E3-B9B5-4B64-9D37-222D82148B56Q56892727-FA037919-3311-47A2-90DF-A9FE8638D778Q58734384-6837B772-E9AB-4860-B5BA-2AC095E64154
P2860
Pediatric medulloblastoma xenografts including molecular subgroup 3 and CD133+ and CD15+ cells are sensitive to killing by oncolytic herpes simplex viruses.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Pediatric medulloblastoma xeno ...... olytic herpes simplex viruses.
@ast
Pediatric medulloblastoma xeno ...... olytic herpes simplex viruses.
@en
type
label
Pediatric medulloblastoma xeno ...... olytic herpes simplex viruses.
@ast
Pediatric medulloblastoma xeno ...... olytic herpes simplex viruses.
@en
prefLabel
Pediatric medulloblastoma xeno ...... olytic herpes simplex viruses.
@ast
Pediatric medulloblastoma xeno ...... olytic herpes simplex viruses.
@en
P2093
P2860
P921
P356
P1433
P1476
Pediatric medulloblastoma xeno ...... olytic herpes simplex viruses.
@en
P2093
Blake P Moore
Catherine P Langford
Elizabeth A Beierle
G Yancey Gillespie
James M Markert
Tina Etminan
Virginia M Kelly
Xiaosi Han
P2860
P304
P356
10.1093/NEUONC/NOV123
P577
2015-07-16T00:00:00Z